Clinical Trial

KSH01-R02-101 Solid Tumors

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 3, 2023 (before its estimated October 11, 2025 completion). Its status may not reflect the trial's current state.
Summary
1. . safety and tolerance 2. . objective response rate
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-10-11.
Status change: Not Yet Recruiting → Recruiting 2023-03-29
Trial Details
NCT Number NCT05580796
Lead Sponsor TCRx Therapeutics Co.Ltd
Conditions Solid Tumor
Enrollment 50 participants
Start Date 2022-10-11
Primary Completion 2025-10-11 (estimated)
Study Completion 2027-10-11 (estimated)
Updated on ClinicalTrials.gov 2023-04-03